Board of Directors
Chairman : Charles Lin
Director : Yung-Shun Wen
Director : Grand Spirit Investments Limited (Representative : Chen-Yu Fang)
Director : CDIB Capital Healthcare Ventures (Representative : Yi-Jiun Gau)
Independent Director : Shoei-Sheng Lee
Independent Director : Shu-Chin Liang
Independent Director : Su Fnag Yang
Mr. Lin received his BS from Department of Pharmacy of Taiwan University and has over 30 years of experience in the pharmaceutical industry. As Chairman of Lotus, he successfully led Lotus be listed at OTC market and transformed into an international pharma. In 2016, Mr. Lin founded Alar Pharmaceuticals Inc. Withing many years of experience in pharmaceutical R & D, innovation and marketing, perspective international outlook and familiarity with corporate governance concepts, he commits to lead Alar to become an international new pharmaceutical company.
Yung-Shun Wen Ph.D
Dr. Wen received his PhD in Chemistry from the National Taiwan University. He has more than 18 years of experiences in the pharmaceutical industry When he was a director of RD department in a well-known pharmaceutical company, he lead the research and development team to break through technical barriers and let the products be listed in advanced countries such as Europe, America and Japan. Dr. Wen has extensive experience in the research and development resources and team management. He will lead the Alar team to focus on products development and be listed in market in order to enhance the company’s overall value.
Director of Finance
Ms Kang received her MBA from Texas A & M University, Commerce. She has more than 10 years of experience in financial management and accounting and worked in famous listed company in Taiwan and China.